Amir Bacchus
CIK 1890100 · View on SEC EDGAR ↗
First SEC filing: Aug. 8, 2023 · Latest: Aug. 8, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 4, 2023 | PIIIW | A | 1,000,000 | — | — | 2,005,193 Direct | +99.48% | Acquired | (price as of 2026-08-19) |
| April 6, 2023 | PIIIW | A | 188,474 | — | — | 188,474 Indirect | — | Acquired | (price as of 2026-08-19) |
| April 6, 2023 | PIIIW | A | 753,895 | — | — | 753,895 Direct | — | Acquired | (price as of 2026-08-19) |
| April 6, 2023 | PIIIW | A | 251,298 | — | — | 251,298 Indirect | — | Acquired | (price as of 2026-08-19) |
| April 6, 2023 | PIIIW | A | 1,005,193 | — | — | 1,005,193 Direct | — | Acquired | (price as of 2026-08-19) |
| Dec. 3, 2021 | PIIIW | A | 15,032,528 | $1503.25 | $22,597,647,716 | 15,032,528 Direct | — | Acquired | -100.0% (price as of 2026-08-19) |
| Dec. 3, 2021 | PIIIW | A | 3,758,130 | $375.81 | $1,412,342,835 | 3,758,130 Indirect | — | Acquired | -100.0% (price as of 2026-08-19) |
| Dec. 3, 2021 | PIIIW | A | 3,758,130 | — | — | 3,758,130 Indirect | — | Acquired | (price as of 2026-08-19) |
| Dec. 3, 2021 | PIIIW | A | 15,032,528 | — | — | 15,032,528 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 6, 2023 | PIIIW | Warrant | Class A Common Stock (188,474) | $1.13 | April 5, 2028 | 188,474 | Acquired |
| April 6, 2023 | PIIIW | Warrant | Class A Common Stock (753,895) | $1.13 | April 5, 2028 | 753,895 | Acquired |
| Dec. 3, 2021 | PIIIW | Common Units [F3] | Class A Common Stock (3,758,130) | — | — | 3,758,130 | Acquired |
| Dec. 3, 2021 | PIIIW | Common Units [F3] | Class A Common Stock (15,032,528) | — | — | 15,032,528 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PIIIW
Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $600,000 | — | — | — | — | — | — | $600,000 |
| 2024 | $600,000 | — | — | — | — | — | — | $600,000 |
| 2023 | $600,000 | — | $220,000 | — | $180,000 | — | — | $1,000,000 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.